Trust Company of Toledo’s Trevi Therapeutics TRVI Stock Holding History

Trust Company of Toledo’s Portfolio TRVI Stock Details TRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.31M	Sell	124,002 -7,500	-6%	-$109K	0.19%	108
2026 Q1	$1.57M	Buy	131,502 +95,000	+260%	+$1.06M	0.15%	132
2025 Q4	$457K	Hold	36,502	–	–	0.05%	219
2025 Q3	$334K	Hold	36,502	–	–	0.03%	239
2025 Q2	$200K	Hold	36,502	–	–	0.02%	275
2025 Q1	$230K	Hold	36,502	–	–	0.03%	221
2024 Q4	$150K	Hold	36,502	–	–	0.02%	231
2024 Q3	$122K	Hold	36,502	–	–	0.02%	232
2024 Q2	$109K	Hold	36,502	–	–	0.02%	228
2024 Q1	$126K	Hold	36,502	–	–	0.02%	222
2023 Q4	$48.9K	Sell	36,502 -80,643	-69%	-$122K	0.01%	215
2023 Q3	$255K	Sell	117,145 -7,712	-6%	-$17.4K	0.05%	186
2023 Q2	$298K	Buy	124,857 +41,857	+50%	+$105K	0.05%	170
2023 Q1	$154K	Buy	+83,000	New	+$188K	0.03%	194

Other funds holding TRVI

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

NFT

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

CCIA

Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return

PFS Partners Mine Hill, New Jersey $247M AUM 29.02% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Trust Company of Toledo's TRVI Position: Q2 2026 in Review

Trust Company of Toledo reduced its Trevi Therapeutics (TRVI) stake by 5.7% in Q2 2026, selling an estimated $109K and leaving 124,002 shares worth $2.31M. The position accounts for 0.19% of the portfolio, ranked #108.

Trust Company of Toledo first reported a position in TRVI in Q1 2023 and has held it in 14 quarters since. 40 funds tracked by Wall St. Rank hold TRVI as of Q2 2026.

Trust Company of Toledo held 124,002 shares of Trevi Therapeutics worth $2.31M as of Q2 2026.
Trust Company of Toledo sold 7,500 Trevi Therapeutics shares in Q2 2026, an estimated $109K.
Trevi Therapeutics made up 0.19% of Trust Company of Toledo's portfolio in Q2 2026, its #108 holding.
Trust Company of Toledo first reported a position in Trevi Therapeutics in Q1 2023 and has held it in 14 quarters since.
40 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q2 2026.

Based on Trust Company of Toledo's 13F filing for Q2 2026, filed 16 Jul 2026.